This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Chapman, J., Franko, A. & Sharplin, J. A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer 43, 546–550 (1981). https://doi.org/10.1038/bjc.1981.79
Issue Date:
DOI: https://doi.org/10.1038/bjc.1981.79
This article is cited by
-
Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients
Scientific Reports (2022)
-
Prognostic Value of Fluorine-19 MRI Oximetry Monitoring in cancer
Molecular Imaging and Biology (2022)
-
The feasibility of [18F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study
EJNMMI Research (2020)
-
18F-FMISO PET imaging: insights over MRI in patients with glioma
Clinical and Translational Imaging (2020)
-
Molecular and functional imaging insights into the role of hypoxia in cancer aggression
Cancer and Metastasis Reviews (2019)